LeafyWell, PYTG's Subsidiary, Announces To-date 1st Quarter Revenues 2019 Expected to Surpass 2018 Final-Quarter Sales.

WESTON, Florida, Feb. 20, 2019 /PRNewswire/ -- During the final quarter of 2018, Pyramidion Technology Group, Inc. (OTCPK: PYTG) (PYTG) acquired NxGen Brands, LLC and became the proud owner of LeafyWell (LeafyWell.com), and shortly thereafter announced the finalization of a contractual agreement to provide custom cannabidiol (CBD)-product formulations to Emergent Health, Corp., including the first product of its kind for both companies consisting of an ingredient trifecta designed to aid in sleep, anxiety, and mood: CBD, Melatonin, and GABA. Additionally, during the final quarter of 2018, PYTG announced the execution of a binding letter of intent to acquire Renaissance Health Publishing, LLC. – a private Florida-based company specializing in health and wellness supplements.

During the same quarter, PYTG, by way of LeafyWell (LeafyWell.com), officially launched a full line of CBD-infused pet treats in addition to their already-established line of hemp-based CBD-infused supplements such as tinctures/oils, creams, lotions, edible gummies, available at both wholesale and retail levels. CBD should be considered a notable discussion topic in the medical community, the research community, and the patient community. CBD research has provided evidentiary findings demonstrating its potentially beneficial symptomatic relief for vast range of ailments, including rheumatoid arthritis, diabetes, alcoholism, post-traumatic stress disorder, epilepsy, antibiotic-resistant infections, neurological disorders, chronic pain, and muscular dystrophy, among others.

PYTG announces today that revenues of LeafyWell (LeafyWell.com) products online, wholesale, distributors, formulating, and private labeling, to date in the first fiscal quarter of 2019 alone, are expected to officially surpass all revenues during the final calendar-year quarter of 2018. Carlos Hurtado, CEO of PYTG, stated, "We are enthused with the rising success of LeafyWell branded products and the performance of PYTG as a whole. We are certainly pleased to remark on this record-breaking news for LeafyWell and we are looking forward to what is to come for the following fiscal-year quarters. All of us at PYTG are hard at work including our phenomenal Board of Advisors who are guiding us through patient-based needs and related product formulations."

The Board of Advisors for PYTG includes currently-practicing medical professionals such as board-certified cardiologist and board-certified internal medicine physician, Dr. Mark Sabbota, family medicine specialist, Dr. Michael McKenzie, MD, Dr. David M. Feldbaum MD, FACS, certified in vascular surgery by the American Board of Surgery, Dr. Javier J. Canasi, with a specialization in internal medicine who is advocate of alternative medicine including the inclusion of both hemp-based CBD products, marijuana-based CBD, and medicinal marijuana, when appropriate for the particular medical condition that ails some patients, and in addition to other industry-specific board members.

Mr. Hurtado, continues to explain, "We anticipate that our current shareholders will be equally elated to learn the news that we are on target to successfully surpass our final-quarter 2018 revenues of our CBD hemp-derived supplements, including those manufactured by LeafyWell, solely during this short period of time in 2019. As a company, we expect to continue to move forward on many fronts, and we expect that this news is just the tip of the iceberg of what is ahead in a big way." In fact this week, we made the news in Peoria, Illinois where specialty retailers are currently selling a wide variety of our CBD product line LeafyWell, and pet CBD treats is now sold. This is excellent publicity on all levels for LeafyWell, with more to come." Please click here for more detail: https://www.centralillinoisproud.com/news/local-news/cbd-store-opening-in-grand-prairie/1790968133

About Pyramidion Technology Group, Inc.

Pyramidion Technology Group, Inc is a business conglomerate that owns and now operates two (2) subsidiaries 100%. Our pursuit is to leverage equity, acquire, merge and or joint venture with early-stage companies in emerging industries, reinvigorating growth and cash flow positioning broader distribution channels. Pyramidion Technology Group, Inc is pioneering and acquiring fast-growing companies in up-trending industries and utilizing technology for economies of scope.

Currently, one of our principal companies is NxGen Brands, LLC d/b/a: LeafyWell or (http://www.LeafyWell.com ), formulating, manufacturing, distributing, marketing and white labeling a wide variety of non-THC Broad Spectrum CBD supplements.

MyIAD or (http://www.MyIAD.com ), is our technology developer exploiting state-of-the-art wearable Global Positioning System "GPS" and Global Mobile Communications "GSM" for tracking and monitoring assets specifically in healthcare. As well as innovating a seed-to-sale real-time software utility platform for the hemp and cannabis industry validating origin and authenticity. In summary, our overall business goals could effectively create unlimited opportunities for our growing shareholder base.

For more information on PYTG, please visit the Company's website at https://www.pytgcorp.com.

To be added to the Company investor email list, please email [email protected] with PYTG in the subject line.

FORWARD-LOOKING STATEMENTS

This press release contains forward-looking statements as defined within Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These statements relate to future events, including our ability to raise capital, or to our future financial performance, and involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance, or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. You should not place undue reliance on forward-looking statements since they involve known and unknown risks, uncertainties and other factors which are, in some cases, beyond our control and which could, and likely will, materially affect actual results, levels of activity, performance or achievements. Any forward-looking statement reflects our current views with respect to future events and is subject to these and other risks, uncertainties and assumptions relating to our operations, results of operations, growth strategy and liquidity. We assume no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future.

For a discussion of these risks and uncertainties, please see our filings with the OTC Markets Group Inc. Our public filings with the OTC Markets Group Inc are available from commercial document retrieval services and at the website maintained by the OTC Markets at https://www.otcmarkets.com/stock/PYTG/filings.

Contact:
[email protected]
Phone: +1-954-651-6816

SOURCE Pyramidion Technology Group, Inc.